BioXcel Therapeutics (BTAI) Shares Outstanding (2017 - 2026)

BioXcel Therapeutics' Shares Outstanding history runs 10 years deep, the most recent figure standing at $27.1 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 395.15% year-over-year to $27.1 million; the TTM figure through Mar 2026 stood at $27.1 million (up 395.15% YoY), while the FY2025 annual figure was $22.3 million, up 619.79% from the prior year.
• Shares Outstanding was $27.1 million for Q1 2026 at BioXcel Therapeutics, up from $22.3 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $29.3 million in Q3 2023 to a low of $1.8 million in Q4 2022.
• Historically, Shares Outstanding has averaged $15.7 million across 5 years, with a median of $20.0 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding sank 93.71% in 2022, then surged 653.43% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $1.8 million in 2022, then climbed by 6.37% to $1.9 million in 2023, then jumped by 65.79% to $3.1 million in 2024, then soared by 619.79% to $22.3 million in 2025, then grew by 21.26% to $27.1 million in 2026.
• The last three Shares Outstanding figures came in at $27.1 million (Q1 2026), $22.3 million (Q4 2025), and $20.0 million (Q3 2025), per Business Quant data.